On the heels of extraordinarily successful results announced by four coronavirus disease 2019 (COVID-19) vaccine developers within three weeks of one another, the question of whether developing countries will be “left behind” continues. COVAX (one of the three pillars of the Access to COVID-19 Tools (ACT) Accelerator), a massively funded global collaboration involving 187 countries, aims to ensure that they…